Results 201 to 210 of about 3,403,581 (279)

Rethinking tau‐targeted therapy in Alzheimer's disease: Toward a dual biomarker strategy

open access: yesAlzheimer's &Dementia, Volume 22, Issue 9, September 2026.
Abstract Tau pathology is more closely associated with cognitive deterioration than amyloid burden in symptomatic Alzheimer's disease (AD), yet tau‐targeted trials have often interpreted decreases in soluble phosphorylated tau (p‐tau) as evidence of therapeutic success. Emerging data argue for a more biology‐informed framework.
Charlotte E. Teunissen   +2 more
wiley   +1 more source

Therapeutic Potential of Oxiracetam in Neurocognitive Disorders: A Narrative Review

open access: yesBrain and Behavior, Volume 16, Issue 9, September 2026.
ABSTRACT Purpose: Cognitive impairment is a growing global health concern associated with aging, neurodegenerative diseases, stroke, and traumatic brain injury. Existing pharmacological treatments, including cholinesterase inhibitors and memantine, provide limited and variable benefits.
Hafsa Ali   +4 more
wiley   +1 more source

Antiglycation and Amyloid‐β Inhibitory Activities of Pandanus odorifer Extracts and Isolated Constituents: In Vitro and Molecular Docking Insights

open access: yesChemistry &Biodiversity, Volume 23, Issue 9, September 2026.
Pandanus odorifer methanolic extract exhibited strong antiglycation activity, moderate antioxidant capacity, and high flavonoid content. Three isolated compounds reduced Aβ‐associated ThT fluorescence, with blumenol C glucoside showing the greatest effect.
Patricia Marie P. Oliva   +4 more
wiley   +1 more source

Moringa oleifera Lam. Seed Lectin (WSMoL) Attenuates Parkinsonian Symptoms in Mice via Anti‐Inflammatory, Antioxidant, and Neurotransmitter‐Modulating Effects

open access: yesChemistry &Biodiversity, Volume 23, Issue 9, September 2026.
WSMoL attenuates motor impairment, neuroinflammation, oxidative stress, and monoamine depletion in a rotenone‐induced model of Parkinson's disease. The involvement of D1 receptor‐mediated signaling is demonstrated, providing new insights into the mechanisms underlying its neuroprotective effects and supporting WSMoL as a promising candidate for further
Leydianne Leite de Siqueira Patriota   +14 more
wiley   +1 more source

Chronic Paraquat Neurotoxicity and Dopaminergic Degeneration: A Mechanistic Review

open access: yesChemistry &Biodiversity, Volume 23, Issue 9, September 2026.
Occurrence of Parkinson's disease (PD) based on several neurotoxins. Advanced and comprehensive mechanisms based on Paraquat‐induced PD. Mechanism of oxidative stress, ROS and RNS formation, and death of dopaminergic neurons. The modulation of genes and proteins by paraquat leads to Parkinsonism.
Saima Riaz   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy